Cansortium Inc. (OTCMKTS:CNTMF) Sees Large Drop in Short Interest

Cansortium Inc. (OTCMKTS:CNTMF) was the target of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totaling 41,835 shares, a decrease of 83.9% from the June 15th total of 260,061 shares. Based on an average daily volume of 1,061,571 shares, the short-interest ratio is currently 0.0 days.

Cansortium Trading Up 9.9%

OTCMKTS:CNTMF traded up $0.00 during trading hours on Monday, reaching $0.02. 61,037 shares of the company’s stock were exchanged, compared to its average volume of 451,291. Cansortium has a 12 month low of $0.02 and a 12 month high of $0.09. The business’s 50-day simple moving average is $0.02 and its two-hundred day simple moving average is $0.03.

Cansortium (OTCMKTS:CNTMF) last posted its quarterly earnings results on Thursday, April 30th. The company reported ($0.16) earnings per share (EPS) for the quarter. During the same quarter in the prior year, the company earned ($0.14) earnings per share.

About Cansortium

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.